Title All-cause mortality risk in National Prostate Cancer Cohort: an impact of population-based prostate cancer screening /
Authors Patašius, Aušvydas ; Smailytė, Giedrė
DOI 10.3390/jcm10112459
Full Text Download
Is Part of Journal of clinical medicine.. Basel : MDPI. 2021, vol. 10, iss. 11, art. no. 2459, p. [1-7].. ISSN 2077-0383
Keywords [eng] all-cause mortality ; cause-specific mortality ; mortality risk ; prostate cancer ; screening
Abstract [eng] The aim of this study is to evaluate all-cause mortality risk differences before and during prostate cancer screening, with a profound focus on the differences between screened and not-screened patient groups. Prostate cancer cases diagnosed between 1998 and 2016 were identified from the population-based Lithuanian Cancer Registry and linked with screening status in the National Health Insurance Fund database. The analysis was stratified by a period of diagnosis and screening status. Standardized mortality ratios (SMRs) were used to assess all-cause and cause-specific mortality risk. The SMRs were calculated by dividing the observed number of deaths among prostate cancer patients by the expected number of deaths from the general population. All-cause SMR (1.45 (95% CI 1.42-1.48)) in the pre-screening period was higher compared to the screening period (SMR = 1.17 (95% CI 1.15-1.19)). An increased all-cause mortality risk among prostate cancer patients was observed in the not-screened patient population (SMR = 1.76 (95% CI 1.71-1.82)), while all-cause mortality risk in the screened patient population was similar to the general population (SMR = 1.00 (95% CI 0.97-1.02)). Screened patients with localized stage of disease had lower all-cause mortality risk than the general population (SMR = 0.72 (95% CI 0.70-0.75)). In conclusion, men with prostate cancer in Lithuania had excess all-cause mortality risk compared to the general population. The all-cause mortality risk among screened patients was not higher than expected.
Published Basel : MDPI
Type Journal article
Language English
Publication date 2021
CC license CC license description